-
1
-
-
0030744876
-
Mutation in the alphasynuclein gene identified in families with Parkinson's disease
-
Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alphasynuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-7
-
(1997)
Science
, vol.276
, pp. 2045-2047
-
-
Polymeropoulos, M.H.1
Lavedan, C.2
Leroy, E.3
-
2
-
-
0031990490
-
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
-
Kruger R, Kuhn W, Muller T, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 1998;18: 106-8
-
(1998)
Nat Genet
, vol.18
, pp. 106-108
-
-
Kruger, R.1
Kuhn, W.2
Muller, T.3
-
3
-
-
10744230149
-
The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia
-
Zarranz JJ, Alegre J, Gomez-Esteban JC, et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 2004;55:164-73
-
(2004)
Ann Neurol
, vol.55
, pp. 164-173
-
-
Zarranz, J.J.1
Alegre, J.2
Gomez-Esteban, J.C.3
-
4
-
-
4644290985
-
Alpha-synuclein locus duplication as a cause of familial Parkinson's disease
-
Chartier-Harlin MC, Kachergus J, Roumier C, et al. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 2004; 364:1167-9
-
(2004)
Lancet
, vol.364
, pp. 1167-1169
-
-
Chartier-Harlin, M.C.1
Kachergus, J.2
Roumier, C.3
-
5
-
-
4644236043
-
Causal relation between alphasynuclein gene duplication and familial Parkinson's disease
-
Ibanez P, Bonnet AM, Debarges B, et al. Causal relation between alphasynuclein gene duplication and familial Parkinson's disease. Lancet 2004;364:1169-71
-
(2004)
Lancet
, vol.364
, pp. 1169-1171
-
-
Ibanez, P.1
Bonnet, A.M.2
Debarges, B.3
-
6
-
-
32044453611
-
Clinical heterogeneity of alphasynuclein gene duplication in Parkinson's disease
-
Nishioka K, Hayashi S, Farrer MJ, et al. Clinical heterogeneity of alphasynuclein gene duplication in Parkinson's disease. Ann Neurol 2006;59: 298-309
-
(2006)
Ann Neurol
, vol.59
, pp. 298-309
-
-
Nishioka, K.1
Hayashi, S.2
Farrer, M.J.3
-
7
-
-
34147109175
-
Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication
-
Fuchs J, Nilsson C, Kachergus J, et al. Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology 2007;68:916-22
-
(2007)
Neurology
, vol.68
, pp. 916-922
-
-
Fuchs, J.1
Nilsson, C.2
Kachergus, J.3
-
8
-
-
0242300619
-
alpha-Synuclein locus triplication causes Parkinson's disease
-
Singleton AB, Farrer M, Johnson J, et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science 2003;302:841
-
(2003)
Science
, vol.302
, pp. 841
-
-
Singleton, A.B.1
Farrer, M.2
Johnson, J.3
-
9
-
-
10744227740
-
Comparison of kindreds with Parkinsonism and alpha-synuclein genomic multiplications
-
Farrer M, Kachergus J, Forno L, et al. Comparison of kindreds with Parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 2004;55:174-9
-
(2004)
Ann Neurol
, vol.55
, pp. 174-179
-
-
Farrer, M.1
Kachergus, J.2
Forno, L.3
-
10
-
-
0033933048
-
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
-
Shimura H, Hattori N, Kubo S, et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 2000; 25:302-5
-
(2000)
Nat Genet
, vol.25
, pp. 302-305
-
-
Shimura, H.1
Hattori, N.2
Kubo, S.3
-
11
-
-
27944444154
-
Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive Parkinsonism
-
Silvestri L, Caputo V, Bellacchio E, et al. Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive Parkinsonism. Hum Mol Genet 2005;14:3477-92
-
(2005)
Hum Mol Genet
, vol.14
, pp. 3477-3492
-
-
Silvestri, L.1
Caputo, V.2
Bellacchio, E.3
-
12
-
-
1642527499
-
DJ-1 has a role in antioxidative stress to prevent cell death
-
Taira T, Saito Y, Niki T, et al. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep 2004;5:213-8
-
(2004)
EMBO Rep
, vol.5
, pp. 213-218
-
-
Taira, T.1
Saito, Y.2
Niki, T.3
-
13
-
-
30644471051
-
Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death
-
Martin LJ, Pan Y, Price AC, et al. Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci 2006;26:41-50
-
(2006)
J Neurosci
, vol.26
, pp. 41-50
-
-
Martin, L.J.1
Pan, Y.2
Price, A.C.3
-
14
-
-
34249946941
-
Mono-and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage
-
Stichel CC, Zhu XR, Bader V, et al. Mono-and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage. Hum Mol Genet 2007;16:2377-93
-
(2007)
Hum Mol Genet
, vol.16
, pp. 2377-2393
-
-
Stichel, C.C.1
Zhu, X.R.2
Bader, V.3
-
15
-
-
33646476833
-
Increased sensitivity to MPTP in human alpha-synuclein A30P transgenic mice
-
Nieto M, Gil-Bea FJ, Dalfo E, et al. Increased sensitivity to MPTP in human alpha-synuclein A30P transgenic mice. Neurobiol Aging 2006;27: 848-56
-
(2006)
Neurobiol Aging
, vol.27
, pp. 848-856
-
-
Nieto, M.1
Gil-Bea, F.J.2
Dalfo, E.3
-
16
-
-
1542617769
-
Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP
-
Song DD, Shults CW, Sisk A, et al. Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp Neurol 2004;186:158-72
-
(2004)
Exp Neurol
, vol.186
, pp. 158-172
-
-
Song, D.D.1
Shults, C.W.2
Sisk, A.3
-
17
-
-
0037195109
-
Resistance of alpha-synuclein null mice to the Parkinsonian neurotoxin MPTP
-
Dauer W, Kholodilov N, Vila M, et al. Resistance of alpha-synuclein null mice to the Parkinsonian neurotoxin MPTP. Proc Natl Acad Sci U S A 2002;99:14524-9
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 14524-14529
-
-
Dauer, W.1
Kholodilov, N.2
Vila, M.3
-
18
-
-
3542993306
-
Mice lacking alphasynuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration
-
Drolet RE, Behrouz B, Lookingland KJ, et al. Mice lacking alphasynuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration. Neurotoxicology 2004;25: 761-9
-
(2004)
Neurotoxicology
, vol.25
, pp. 761-769
-
-
Drolet, R.E.1
Behrouz, B.2
Lookingland, K.J.3
-
19
-
-
20044385568
-
Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitinproteasome system and alpha-synuclein
-
Fornai F, Schluter OM, Lenzi P, et al. Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitinproteasome system and alpha-synuclein. Proc Natl Acad Sci U S A 2005; 102:3413-8
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 3413-3418
-
-
Fornai, F.1
Schluter, O.M.2
Lenzi, P.3
-
20
-
-
33745612296
-
Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system
-
Betarbet R, Canet-Aviles RM, Sherer TB, et al. Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system. Neurobiol Dis 2006;22:404-20
-
(2006)
Neurobiol Dis
, vol.22
, pp. 404-420
-
-
Betarbet, R.1
Canet-Aviles, R.M.2
Sherer, T.B.3
-
21
-
-
0033577159
-
Oxidative stress induces amyloidlike aggregate formation of NACP/alpha-synuclein in vitro
-
Hashimoto M, Hsu LJ, Xia Y, et al. Oxidative stress induces amyloidlike aggregate formation of NACP/alpha-synuclein in vitro. Neuroreport 1999;10:717-21
-
(1999)
Neuroreport
, vol.10
, pp. 717-721
-
-
Hashimoto, M.1
Hsu, L.J.2
Xia, Y.3
-
22
-
-
0034674652
-
Dityrosine cross-linking promotes formation of stable alpha-synuclein polymers Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies
-
Souza JM, Giasson BI, Chen Q, et al. Dityrosine cross-linking promotes formation of stable alpha-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J Biol Chem 2000;275:18344-9
-
(2000)
J Biol Chem
, vol.275
, pp. 18344-18349
-
-
Souza, J.M.1
Giasson, B.I.2
Chen, Q.3
-
23
-
-
0036316947
-
Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures
-
McNaught KS, Mytilineou C, Jnobaptiste R, et al. Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures. J Neurochem 2002;81:301-6
-
(2002)
J Neurochem
, vol.81
, pp. 301-306
-
-
McNaught, K.S.1
Mytilineou, C.2
Jnobaptiste, R.3
-
24
-
-
0037036904
-
Proteasome inhibition causes nigral degeneration with inclusion bodies in rats
-
McNaught KS, Bjorklund LM, Belizaire R, et al. Proteasome inhibition causes nigral degeneration with inclusion bodies in rats. Neuroreport 2002;13:1437-41
-
(2002)
Neuroreport
, vol.13
, pp. 1437-1441
-
-
McNaught, K.S.1
Bjorklund, L.M.2
Belizaire, R.3
-
25
-
-
0030982120
-
The role of reactive oxygen species in mitochondrial permeability transition
-
Vercesi AE, Kowaltowski AJ, Grijalba MT, et al. The role of reactive oxygen species in mitochondrial permeability transition. Biosci Rep 1997; 17:43-52
-
(1997)
Biosci Rep
, vol.17
, pp. 43-52
-
-
Vercesi, A.E.1
Kowaltowski, A.J.2
Grijalba, M.T.3
-
26
-
-
18344366874
-
Role of mitochondria in oxidative stress and aging
-
Lenaz G, Bovina C, D'Aurelio M, et al. Role of mitochondria in oxidative stress and aging. Ann N Y Acad Sci 2002;959:199-213
-
(2002)
Ann N Y Acad Sci
, vol.959
, pp. 199-213
-
-
Lenaz, G.1
Bovina, C.2
D'Aurelio, M.3
-
27
-
-
0017154414
-
Role of ubiquinone in the mitochondrial generation of hydrogen peroxide
-
Boveris A, Cadenas E, Stoppani AO. Role of ubiquinone in the mitochondrial generation of hydrogen peroxide. Biochem J 1976;156:435-44
-
(1976)
Biochem J
, vol.156
, pp. 435-444
-
-
Boveris, A.1
Cadenas, E.2
Stoppani, A.O.3
-
28
-
-
0017406503
-
Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinolcytochrome c reductase from beef-heart mitochondria
-
Cadenas E, Boveris A, Ragan CI, et al. Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinolcytochrome c reductase from beef-heart mitochondria. Arch Biochem Biophys 1977;180:248-57
-
(1977)
Arch Biochem Biophys
, vol.180
, pp. 248-257
-
-
Cadenas, E.1
Boveris, A.2
Ragan, C.I.3
-
29
-
-
0019083215
-
Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria
-
Turrens JF, Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J 1980;191:421-7
-
(1980)
Biochem J
, vol.191
, pp. 421-427
-
-
Turrens, J.F.1
Boveris, A.2
-
30
-
-
0141741347
-
Parkinson's disease: mechanisms and models
-
Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003;39:889-909
-
(2003)
Neuron
, vol.39
, pp. 889-909
-
-
Dauer, W.1
Przedborski, S.2
-
31
-
-
0029053451
-
Superoxide radical and superoxide dismutases
-
Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem 1995;64:97-112
-
(1995)
Annu Rev Biochem
, vol.64
, pp. 97-112
-
-
Fridovich, I.1
-
32
-
-
0029842654
-
Modulation of oxygen-radicalscavenging enzymes by oxidative stress in primary cultures of rat astroglial cells
-
Pinteaux E, Copin JC, Ledig M, et al. Modulation of oxygen-radicalscavenging enzymes by oxidative stress in primary cultures of rat astroglial cells. Dev Neurosci 1996;18:397-404
-
(1996)
Dev Neurosci
, vol.18
, pp. 397-404
-
-
Pinteaux, E.1
Copin, J.C.2
Ledig, M.3
-
33
-
-
0030417936
-
Redox regulation of manganese superoxide dismutase
-
Warner BB, Stuart L, Gebb S, et al. Redox regulation of manganese superoxide dismutase. Am J Physiol 1996;271:L150-8
-
(1996)
Am J Physiol
, vol.271
, pp. L150-L158
-
-
Warner, B.B.1
Stuart, L.2
Gebb, S.3
-
34
-
-
0028308792
-
Distribution of manganesedependent superoxide dismutase in the human brain
-
Zhang P, Anglade P, Hirsch EC, et al. Distribution of manganesedependent superoxide dismutase in the human brain. Neuroscience 1994; 61:317-30
-
(1994)
Neuroscience
, vol.61
, pp. 317-330
-
-
Zhang, P.1
Anglade, P.2
Hirsch, E.C.3
-
35
-
-
0035500460
-
Genetic modification of prenatal lethality and dilated cardiomyopathy in Mn superoxide dismutase mutant mice
-
Huang TT, Carlson EJ, Kozy HM, et al. Genetic modification of prenatal lethality and dilated cardiomyopathy in Mn superoxide dismutase mutant mice. Free Radic Biol Med 2001;31:1101-10
-
(2001)
Free Radic Biol Med
, vol.31
, pp. 1101-1110
-
-
Huang, T.T.1
Carlson, E.J.2
Kozy, H.M.3
-
36
-
-
0035956929
-
Increased mitochondrial oxidative stress in the Sod2 (+/-) mouse results in the age-related decline of mitochondrial function culminating in increased apoptosis
-
Kokoszka JE, Coskun P, Esposito LA, et al. Increased mitochondrial oxidative stress in the Sod2 (+/-) mouse results in the age-related decline of mitochondrial function culminating in increased apoptosis. Proc Natl Acad Sci U S A2001;98:2278-83
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 2278-2283
-
-
Kokoszka, J.E.1
Coskun, P.2
Esposito, L.A.3
-
37
-
-
12144288373
-
Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging
-
Van Remmen H, Ikeno Y, Hamilton M, et al. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol Genomics 2003;16: 29-37
-
(2003)
Physiol Genomics
, vol.16
, pp. 29-37
-
-
Van Remmen, H.1
Ikeno, Y.2
Hamilton, M.3
-
38
-
-
0028827252
-
Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase
-
Li Y, Huang TT, Carlson EJ, et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 1995;11:376-81
-
(1995)
Nat Genet
, vol.11
, pp. 376-381
-
-
Li, Y.1
Huang, T.T.2
Carlson, E.J.3
-
39
-
-
0033102629
-
Characterization of the antioxidant status of the heterozygous manganese superoxide dismutase knockout mouse
-
Van Remmen H, Salvador C, Yang H, et al. Characterization of the antioxidant status of the heterozygous manganese superoxide dismutase knockout mouse. Arch Biochem Biophys 1999;363:91-7
-
(1999)
Arch Biochem Biophys
, vol.363
, pp. 91-97
-
-
Van Remmen, H.1
Salvador, C.2
Yang, H.3
-
40
-
-
0029838063
-
Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutasedeficient mice
-
Lebovitz RM, Zhang H, Vogel H, et al. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutasedeficient mice. Proc Natl Acad Sci U S A 1996;93:9782-7
-
(1996)
Proc Natl Acad Sci U S A
, vol.93
, pp. 9782-9787
-
-
Lebovitz, R.M.1
Zhang, H.2
Vogel, H.3
-
41
-
-
0036855635
-
Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies
-
Neumann M, Kahle PJ, Giasson BI, et al. Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies. J Clin Invest 2002;110:1429-39
-
(2002)
J Clin Invest
, vol.110
, pp. 1429-1439
-
-
Neumann, M.1
Kahle, P.J.2
Giasson, B.I.3
-
42
-
-
80054995024
-
Scale: a chemical approach for fluorescence imaging and reconstruction of transparent mouse brain
-
Hama H, Kurokawa H, Kawano H, et al. Scale: a chemical approach for fluorescence imaging and reconstruction of transparent mouse brain. Nat Neurosci 2011;14:1481-8
-
(2011)
Nat Neurosci
, vol.14
, pp. 1481-1488
-
-
Hama, H.1
Kurokawa, H.2
Kawano, H.3
-
43
-
-
33646097224
-
Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders
-
Tofaris GK, Garcia Reitbock P, Humby T, et al. Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders. J Neurosci 2006;26:3942-50
-
(2006)
J Neurosci
, vol.26
, pp. 3942-3950
-
-
Tofaris, G.K.1
Garcia Reitbock, P.2
Humby, T.3
-
44
-
-
0036174010
-
alpha-Synuclein is phosphorylated in synucleinopathy lesions
-
Fujiwara H, HasegawaM, Dohmae N, et al. alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 2002;4:160-4
-
(2002)
Nat Cell Biol
, vol.4
, pp. 160-164
-
-
Fujiwara, H.1
Hasegawa, M.2
Dohmae, N.3
-
45
-
-
34447570901
-
Age-dependent cognitive decline and amygdala pathology in alpha-synuclein transgenic mice
-
Freichel C, Neumann M, Ballard T, et al. Age-dependent cognitive decline and amygdala pathology in alpha-synuclein transgenic mice. Neurobiol Aging 2007;28:1421-35
-
(2007)
Neurobiol Aging
, vol.28
, pp. 1421-1435
-
-
Freichel, C.1
Neumann, M.2
Ballard, T.3
-
46
-
-
0034280435
-
Subcellular localization of wildtype and Parkinson's disease-associated mutant alpha-synuclein in human and transgenic mouse brain
-
Kahle PJ, Neumann M, Ozmen L, et al. Subcellular localization of wildtype and Parkinson's disease-associated mutant alpha-synuclein in human and transgenic mouse brain. J Neurosci 2000;20:6365-73
-
(2000)
J Neurosci
, vol.20
, pp. 6365-6373
-
-
Kahle, P.J.1
Neumann, M.2
Ozmen, L.3
-
47
-
-
64649106275
-
Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice
-
Schell H, Hasegawa T, Neumann M, et al. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice. Neuroscience 2009;160:796-804
-
(2009)
Neuroscience
, vol.160
, pp. 796-804
-
-
Schell, H.1
Hasegawa, T.2
Neumann, M.3
-
48
-
-
0026704075
-
Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia The Royal Kings and Queens Parkinson's Disease Research Group
-
Dexter DT, Jenner P, Schapira AH, et al. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group. Ann Neurol 1992;32(Suppl):S94-100
-
(1992)
Ann Neurol
, vol.32
, pp. S94-100
-
-
Dexter, D.T.1
Jenner, P.2
Schapira, A.H.3
-
49
-
-
0032507983
-
Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases
-
Gu M, Owen AD, Toffa SE, et al. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases. J Neurol Sci 1998;158: 24-9
-
(1998)
J Neurol Sci
, vol.158
, pp. 24-29
-
-
Gu, M.1
Owen, A.D.2
Toffa, S.E.3
-
50
-
-
0027995435
-
Complex I, iron, and ferritin in Parkinson's disease substantia nigra
-
Mann VM, Cooper JM, Daniel SE, et al. Complex I, iron, and ferritin in Parkinson's disease substantia nigra. Ann Neurol 1994;36:876-81
-
(1994)
Ann Neurol
, vol.36
, pp. 876-881
-
-
Mann, V.M.1
Cooper, J.M.2
Daniel, S.E.3
-
52
-
-
0028924168
-
Oxidative stress in Parkinson's disease
-
Schapira AH. Oxidative stress in Parkinson's disease. Neuropathol Appl Neurobiol 1995;21:3-9
-
(1995)
Neuropathol Appl Neurobiol
, vol.21
, pp. 3-9
-
-
Schapira, A.H.1
-
53
-
-
0024390719
-
Mitochondrial complex I deficiency in Parkinson's disease
-
Schapira AH, Cooper JM, Dexter D, et al. Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1989;1:1269
-
(1989)
Lancet
, vol.1
, pp. 1269
-
-
Schapira, A.H.1
Cooper, J.M.2
Dexter, D.3
-
54
-
-
33646922865
-
Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice
-
Esposito L, Raber J, Kekonius L, et al. Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J Neurosci 2006;26:5167-79
-
(2006)
J Neurosci
, vol.26
, pp. 5167-5179
-
-
Esposito, L.1
Raber, J.2
Kekonius, L.3
-
55
-
-
2642544767
-
Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice
-
Li F, Calingasan NY, Yu F, et al. Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. J Neurochem 2004; 89:1308-12
-
(2004)
J Neurochem
, vol.89
, pp. 1308-1312
-
-
Li, F.1
Calingasan, N.Y.2
Yu, F.3
-
56
-
-
51349087228
-
MnSOD deficiency has a differential effect on disease progression in two different ALS mutant mouse models
-
Muller FL, Liu Y, Jernigan A, et al. MnSOD deficiency has a differential effect on disease progression in two different ALS mutant mouse models. Muscle Nerve 2008;38:1173-83
-
(2008)
Muscle Nerve
, vol.38
, pp. 1173-1183
-
-
Muller, F.L.1
Liu, Y.2
Jernigan, A.3
-
57
-
-
0034614415
-
Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein
-
Okochi M, Walter J, Koyama A, et al. Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein. J Biol Chem 2000; 275:390-7
-
(2000)
J Biol Chem
, vol.275
, pp. 390-397
-
-
Okochi, M.1
Walter, J.2
Koyama, A.3
-
58
-
-
0034681163
-
Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy
-
Conway KA, Lee SJ, Rochet JC, et al. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc Natl Acad Sci U S A 2000;97:571-6
-
(2000)
Proc Natl Acad Sci U S A
, vol.97
, pp. 571-576
-
-
Conway, K.A.1
Lee, S.J.2
Rochet, J.C.3
-
59
-
-
13844320376
-
Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations
-
Li W, West N, Colla E, et al. Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations. Proc Natl Acad Sci U S A 2005;102:2162-7
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 2162-2167
-
-
Li, W.1
West, N.2
Colla, E.3
-
60
-
-
28444458083
-
Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation
-
Liu IH, Uversky VN, Munishkina LA, et al. Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation. Glycobiology 2005;15: 1320-31
-
(2005)
Glycobiology
, vol.15
, pp. 1320-1331
-
-
Liu, I.H.1
Uversky, V.N.2
Munishkina, L.A.3
-
61
-
-
33749570292
-
Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease
-
Anderson JP, Walker DE, Goldstein JM, et al. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem 2006;281: 29739-52
-
(2006)
J Biol Chem
, vol.281
, pp. 29739-29752
-
-
Anderson, J.P.1
Walker, D.E.2
Goldstein, J.M.3
-
62
-
-
0038116620
-
Role of alpha-synuclein carboxy-terminus on fibril formation in vitro
-
Murray IV, Giasson BI, Quinn SM, et al. Role of alpha-synuclein carboxy-terminus on fibril formation in vitro. Biochemistry 2003;42: 8530-40
-
(2003)
Biochemistry
, vol.42
, pp. 8530-8540
-
-
Murray, I.V.1
Giasson, B.I.2
Quinn, S.M.3
-
63
-
-
0034712918
-
Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation
-
Serpell LC, Berriman J, Jakes R, et al. Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. Proc Natl Acad Sci U S A2000;97:4897-902
-
(2000)
Proc Natl Acad Sci U S A
, vol.97
, pp. 4897-4902
-
-
Serpell, L.C.1
Berriman, J.2
Jakes, R.3
-
64
-
-
42649142233
-
Characterization of conformational and dynamic properties of natively unfolded human and mouse alphasynuclein ensembles by NMR: implication for aggregation
-
Wu KP, Kim S, Fela DA, et al. Characterization of conformational and dynamic properties of natively unfolded human and mouse alphasynuclein ensembles by NMR: implication for aggregation. J Mol Biol 2008;378:1104-15
-
(2008)
J Mol Biol
, vol.378
, pp. 1104-1115
-
-
Wu, K.P.1
Kim, S.2
Fela, D.A.3
-
65
-
-
24744461907
-
Familial mutants of alpha-synuclein with increased neurotoxicity have a destabilized conformation
-
Bertoncini CW, Fernandez CO, Griesinger C, et al. Familial mutants of alpha-synuclein with increased neurotoxicity have a destabilized conformation. J Biol Chem 2005;280:30649-52
-
(2005)
J Biol Chem
, vol.280
, pp. 30649-30652
-
-
Bertoncini, C.W.1
Fernandez, C.O.2
Griesinger, C.3
-
66
-
-
20744442130
-
A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease
-
Liu CW, Giasson BI, Lewis KA, et al. A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease. J Biol Chem 2005; 280:22670-8
-
(2005)
J Biol Chem
, vol.280
, pp. 22670-22678
-
-
Liu, C.W.1
Giasson, B.I.2
Lewis, K.A.3
-
67
-
-
77955141273
-
Co-expression of C-terminal truncated alpha-synuclein enhances full-length alpha-synuclein-induced pathology
-
Ulusoy A, Febbraro F, Jensen PH, et al. Co-expression of C-terminal truncated alpha-synuclein enhances full-length alpha-synuclein-induced pathology. Eur J Neurosci 2010;32:409-22
-
(2010)
Eur J Neurosci
, vol.32
, pp. 409-422
-
-
Ulusoy, A.1
Febbraro, F.2
Jensen, P.H.3
-
68
-
-
33947505619
-
Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo
-
Periquet M, Fulga T, Myllykangas L, et al. Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo. J Neurosci 2007;27: 3338-46
-
(2007)
J Neurosci
, vol.27
, pp. 3338-3346
-
-
Periquet, M.1
Fulga, T.2
Myllykangas, L.3
-
69
-
-
39749196233
-
Selective loss of nigral dopamine neurons induced by overexpression of truncated human alpha-synuclein in mice
-
Wakamatsu M, Ishii A, Iwata S, et al. Selective loss of nigral dopamine neurons induced by overexpression of truncated human alpha-synuclein in mice. Neurobiol Aging 2008;29:574-85
-
(2008)
Neurobiol Aging
, vol.29
, pp. 574-585
-
-
Wakamatsu, M.1
Ishii, A.2
Iwata, S.3
-
70
-
-
84856002072
-
Early induction of oxidative stress in mouse model of Alzheimer disease with reduced mitochondrial superoxide dismutase activity
-
Lee HP, Pancholi N, Esposito L, et al. Early induction of oxidative stress in mouse model of Alzheimer disease with reduced mitochondrial superoxide dismutase activity. PLoS One 2012;7:e28033
-
(2012)
PLoS One
, vol.7
-
-
Lee, H.P.1
Pancholi, N.2
Esposito, L.3
-
71
-
-
0037127197
-
The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein
-
Manning-Bog AB, McCormack AL, Li J, et al. The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J Biol Chem 2002;277:1641-4
-
(2002)
J Biol Chem
, vol.277
, pp. 1641-1644
-
-
Manning-Bog, A.B.1
McCormack, A.L.2
Li, J.3
-
72
-
-
85026547975
-
Proteostasis, oxidative stress and aging
-
Korovila I, Hugo M, Castro JP, et al. Proteostasis, oxidative stress and aging. Redox Biol 2017;13:550-67
-
(2017)
Redox Biol
, vol.13
, pp. 550-567
-
-
Korovila, I.1
Hugo, M.2
Castro, J.P.3
-
73
-
-
84960348747
-
Walking the tightrope: proteostasis and neurodegenerative disease
-
Yerbury JJ, Ooi L, Dillin A, et al. Walking the tightrope: proteostasis and neurodegenerative disease. J Neurochem 2016;137:489-505
-
(2016)
J Neurochem
, vol.137
, pp. 489-505
-
-
Yerbury, J.J.1
Ooi, L.2
Dillin, A.3
-
74
-
-
84869109864
-
Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice
-
Luk KC, Kehm V, Carroll J, et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 2012;338:949-53
-
(2012)
Science
, vol.338
, pp. 949-953
-
-
Luk, K.C.1
Kehm, V.2
Carroll, J.3
-
75
-
-
84907015989
-
Brain injection of alphasynuclein induces multiple proteinopathies, gliosis, and a neuronal injury marker
-
Sacino AN, Brooks M, McKinney AB, et al. Brain injection of alphasynuclein induces multiple proteinopathies, gliosis, and a neuronal injury marker. J Neurosci 2014;34:12368-78
-
(2014)
J Neurosci
, vol.34
, pp. 12368-12378
-
-
Sacino, A.N.1
Brooks, M.2
McKinney, A.B.3
-
76
-
-
84934983329
-
alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration
-
Peelaerts W, Bousset L, Van der Perren A, et al. alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 2015;522:340-4
-
(2015)
Nature
, vol.522
, pp. 340-344
-
-
Peelaerts, W.1
Bousset, L.2
Van der Perren, A.3
-
77
-
-
84959020553
-
Induction of de novo alphasynuclein fibrillization in a neuronal model for Parkinson's disease
-
Fares MB, Maco B, Oueslati A, et al. Induction of de novo alphasynuclein fibrillization in a neuronal model for Parkinson's disease. Proc Natl Acad Sci USA 2016;113:E912-21
-
(2016)
Proc Natl Acad Sci USA
, vol.113
, pp. E912-E921
-
-
Fares, M.B.1
Maco, B.2
Oueslati, A.3
-
78
-
-
44749083979
-
Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein
-
Lee HJ, Suk JE, Bae EJ, et al. Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein. Int J Biochem Cell Biol 2008; 40:1835-49
-
(2008)
Int J Biochem Cell Biol
, vol.40
, pp. 1835-1849
-
-
Lee, H.J.1
Suk, J.E.2
Bae, E.J.3
-
79
-
-
77951541740
-
Lysosomal degradation of alpha-synuclein in vivo
-
Mak SK, McCormack AL, Manning-Bog AB, et al. Lysosomal degradation of alpha-synuclein in vivo. J Biol Chem 2010;285:13621-9
-
(2010)
J Biol Chem
, vol.285
, pp. 13621-13629
-
-
Mak, S.K.1
McCormack, A.L.2
Manning-Bog, A.B.3
-
80
-
-
84982273292
-
Proteolysis of alphasynuclein fibrils in the lysosomal pathway limits induction of inclusion pathology
-
Sacino AN, Brooks MM, Chakrabarty P, et al. Proteolysis of alphasynuclein fibrils in the lysosomal pathway limits induction of inclusion pathology. J Neurochem 2017;140:662-78
-
(2017)
J Neurochem
, vol.140
, pp. 662-678
-
-
Sacino, A.N.1
Brooks, M.M.2
Chakrabarty, P.3
-
81
-
-
85027169554
-
Impaired endo-lysosomal membrane integrity accelerates the seeding progression of alpha-synuclein aggregates
-
Jiang P, Gan M, Yen SH, et al. Impaired endo-lysosomal membrane integrity accelerates the seeding progression of alpha-synuclein aggregates. Sci Rep 2017;7:7690
-
(2017)
Sci Rep
, vol.7
, pp. 7690
-
-
Jiang, P.1
Gan, M.2
Yen, S.H.3
-
82
-
-
85027319751
-
Selective imaging of internalized proteopathic alpha-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies
-
Karpowicz RJ, Jr., Haney CM, Mihaila TS, et al. Selective imaging of internalized proteopathic alpha-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies. J Biol Chem 2017;292:13482-97
-
(2017)
J Biol Chem
, vol.292
, pp. 13482-13497
-
-
Karpowicz, R.J.1
Haney, C.M.2
Mihaila, T.S.3
-
83
-
-
85029948737
-
Modeling Parkinson's disease pathology by combination of fibril seeds and alpha-synuclein overexpression in the rat brain
-
Thakur P, Breger LS, Lundblad M, et al. Modeling Parkinson's disease pathology by combination of fibril seeds and alpha-synuclein overexpression in the rat brain. Proc Natl Acad Sci U S A 2017;114: E8284-E93
-
(2017)
Proc Natl Acad Sci U S A
, vol.114
, pp. E8284-E93
-
-
Thakur, P.1
Breger, L.S.2
Lundblad, M.3
-
84
-
-
84862609075
-
Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice
-
Luk KC, Kehm VM, Zhang B, et al. Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J Exp Med 2012;209: 975-86
-
(2012)
J Exp Med
, vol.209
, pp. 975-986
-
-
Luk, K.C.1
Kehm, V.M.2
Zhang, B.3
-
85
-
-
84904636970
-
Intramuscular injection of alpha-synuclein induces CNS alpha-synuclein pathology and a rapidonset motor phenotype in transgenic mice
-
Sacino AN, Brooks M, Thomas MA, et al. Intramuscular injection of alpha-synuclein induces CNS alpha-synuclein pathology and a rapidonset motor phenotype in transgenic mice. Proc Natl Acad Sci U S A 2014;111:10732-7
-
(2014)
Proc Natl Acad Sci U S A
, vol.111
, pp. 10732-10737
-
-
Sacino, A.N.1
Brooks, M.2
Thomas, M.A.3
-
86
-
-
68849110235
-
Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease
-
Dumont M, Wille E, Stack C, et al. Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease. FASEB J 2009;23:2459-66
-
(2009)
FASEB J
, vol.23
, pp. 2459-2466
-
-
Dumont, M.1
Wille, E.2
Stack, C.3
-
87
-
-
69449096141
-
Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer's disease
-
Massaad CA, Washington TM, Pautler RG, et al. Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 2009; 106:13576-81
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 13576-13581
-
-
Massaad, C.A.1
Washington, T.M.2
Pautler, R.G.3
|